Tissue Engineering & 3D Bioprinting represents a revolutionary convergence of biomaterials, cellular biology, and digital fabrication technologies aimed at constructing functional tissues for therapeutic and research applications. Using bioinks composed of living cells and supportive matrices, scientists are now printing complex, multi-layered structures that mimic natural tissue architecture. This technique enables patient-specific constructs for skin, bone, cartilage, and even organ precursors. Tissue Engineering & 3D Bioprinting also supports advancements in disease modeling and drug screening by producing physiologically relevant tissue analogs. Innovations in scaffold design, vascularization, and bioprinter resolution continue to overcome previous limitations, moving the field closer to fully implantable and vascularized organs. Its implications span regenerative medicine, personalized implants, and fundamental biological research.
Title : Biotech innovations: Bioengineering potential for novel biomanufacturing systems
Murray Moo Young, University of Waterloo, Canada
Title : Targeting noncanonical epitopes in anti-cancer immunotherapy
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Stem cell therapy: An affordable healthcare therapy for various diseases
Anant Marathe, Total Potential Cells (P) Ltd, India
Title : Eliminating implant infection: 30,000 nanotextured implants in humans with no failure
Thomas J Webster, Interstellar Therapeutics, United States
Title : Development and characterization of exo-ITC: A fibrous bilayer exosome delivery system for dermatological applications
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Information leakage: Types, remedies, and open problems
Julia Sidorova, Centro de Investigación Biomédica En Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain